New York, New York-- (Newsfile Corp. - March 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, ...

Novo Nordisk stock tumbled Monday after its experimental weight-loss drug failed to top its rival from Eli Lilly in a Phase 3 study.

In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They discuss: How ...

Today, Nu Holdings stock has a market capitalization of approximately $50 billion. Its price-to-earnings ratio ( P/E) on 2024 earnings is 25, which doesn't look overly cheap. However, one doesn't make ...

NEW YORK, NY / ACCESS Newswire / March 7, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE:NVO) between November 2, 2022 and ...

For the final quarter of 2024, the fund gained 1.08%, trailing the 2.41% advance of the benchmark S&P 500® index. Read more ...

Novo Nordisk (NYSE:NVO) is introducing NovoCare Pharmacy, a direct-to-patient delivery option offering Wegovy at a reduced price of $499 per month for certain cash-paying patients.

Asceneuron is the latest biotech to face setbacks in developing tau-targeting therapies for Alzheimer’s. After Eli Lilly and ...

Shares of Hims and Hers (NYSE: HIMS) fell 3% amidst news of Novo Nordisk (NYSE: NVO) introducing NovoCare Pharmacy, which directly impacts the competitive landsca ...

As a measles outbreak in West Texas continues to grow, the response from US Health and Human Services Secretary Robert F.

Bernstein analysts told investors in a note Tuesday that Eli Lilly (NYSE: LLY) is gaining ground in the GLP-1 market, edging ...

FHLC offers diversification with 368 U.S. large-cap holdings, outperforming peer funds. See why I rate the fund a buy.